Loading...
 
Mediterr J Rheumatol 2020;31(2):206-13
Genotype Mutations in Egyptian Children with Familial Mediterranean Fever: Clinical Profile, and Response to Colchicine
Authors Information

1. Department of Pediatrics, Faculty of Medicine, Cairo University, Egypt

2. Ministry of Health, Cairo, Egypt

References
  1. Daniels M, Shohat T, Brenner-Ullman A, Shohat M. Familial Mediterranean fever: high gene frequency among the non-Ashkenazic and Ashkenazic Jewish populations in Israel. Am J Med Genet 1995;55(3):311-410.
  2. Rigante D. A developing portrait of hereditary periodic fevers in childhood. Expert Opin Orphan Drugs 2018;6:47-55.
  3. Ozen S, Batu ED. The myths we believed in familial Mediterranean fever: what have we learned in the past years? Semin Immunopathol 2015; 37(4):363-9.10. 
  4. French FMF Consortium. Localization of the familial Mediterranean fever gene (FMF) to a 250-kb interval in non-Ashkenazi Jewish founder haplotypes. Am J Hum Genet 1996;59:603-12.
  5. Consortium TFF. A candidate gene for familial Mediterranean fever. Nat Genet 1997;17(1):25-31.
  6. Giancane G, Ter Haar N, Wulffraat N, Vastert B, Barron K, Hentgen V, et al. Evidence based recommendations for genetic diagnosis of familial Mediterranean fever. Pediatr Rheumatol Online J  2014;12(Suppl 1):241.
  7. Ben-Chetrit E, Touitou I. Familial Mediterranean fever in the world. Arthritis Rheum 2009;61:1447-53.
  8. Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998;351:659-64.
  9. Soylemezoglu O, Arga M, Fidan K, Gonen S, Emeksiz HC, Hasanoglu E, Buyan N. Unresponsiveness to colchicine therapy in patients with familial Mediterranean fever homozygous for the M694V mutation. J Rheumatol 2010;37:182-9.
  10. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40(10):1879-85.
  11. Sohar E, Gafni G, Pras M. Tel Hashomer key to severity scores for FMF. In: Sohar E, Gafni G, Pras M, eds. Proceedings of the First International Conference on FMF. London and Tel Aviv: Freund Publishing House, 1997:208.
  12. Ahmadinejad Z, Mansori S, Ziaee V, Alijani N, Aghighi Y, Parvaneh N, et al. Periodic fever: a review on clinical, management and guideline for Iranian patients—Part I. Iran J Ped 2014;24(1):1-13.
  13. Onen F. Familial Mediterranean fever. Rheumatol Int 2006;26:489-96.
  14. Düzova A, Özen S. [Ailevi Akdeniz ateşinin kliniği ve tanısı] [Article in Turkish]. Turkiye Klinikleri J Int Med Sci 2006;2:12-20.
  15. Duşunsel R, Dursun I, Gündüz Z, Poyrazoğlu MH, Gürgöze MK, Dundar M. Genotype-phenotype correlation in children with Familial Mediterranean Fever in a Turkish population. Pediatr Int 2008;50:208-12.
  16. Sayarlıoğlu M, Cefle A, Inanç M, Kamali S, Dalkilic E, Gul A, et al. Characteristics of patients with adult-onset familial Mediterranean fever in Turkey: Analysis of 401 cases. Int J Clin Pract 2005;59:202-05.
  17. Ebru E, Deveci SD, Erol D, Yuce H, Elyas H. Familial Mediterranean fever: A Retrospective Clinical and Molecular Study in the East of Anatolia Region of Turkey. Open Rheumatol J 2010;4:1-6.
  18. El-Garf A, Salah S, Iskander I, Salah H, Amin SN. MEFV mutations in Egyptian patients suffering from familial Mediterranean fever: analysis of 12 gene mutations. Rheumatol Int 2010;30:1293-8.
  19. .Settin A, El-Baz R, Abd Rasool M, El-Khalegy H, El-Sayed O, El-Bendary M, et al. Clinical and Molecular Diagnosis of familial Mediterranean fever in Egyptian Children. J Gastrointestin Liver Dis 2007;16(2):141-5.
  20. An online database for autoinflammatory mutations (http://fmf.igh.cnrs.fr/ISSAID/infevers).
  21. El-Shanti H, Majeed HA, El-Khateeb M. Familial Mediterranean fever in Arabs. Lancet 2006;367:1016-24.
  22. Majeed HA, Al-Qudah AK, Qubain H, Shahin HM. The clinical patterns of myalgia in children with familial Mediterranean fever. Semin Arthritis Rheum 2000;30(2):138-43.
  23. Ben-Chetrit E, Urieli-Shoval S, Calko S, Abeliovich D, Matzner Y. Molecular diagnosis of FMF: lessons from a study of 446 unrelated individuals. Clin Exp Rheumatol 2002;20(4):S25-S29.
  24. Ertekin V, Selimoǧlu MA, Pirim I. Familial Mediterranean fever in a childhood population in eastern Turkey. Pediatr Int 2005;47(6):640-4. 
  25. Bonyadi M, Esmaeili M, Karimi A, Dastgiri S. Common mediterranean fever gene mutations in the Azeri Turkish population of Iran. Genet Test Mol Biomark 2010;14(1):149-51.
  26. Salehzadeh F. Familial Mediterranean Fever in Iran: A Report from FMF Registration Center. Int J Rheumatol 2015;2015:912137.
  27. Manna R, Cerquaglia C, Curigliano V, Fonnesu C, Giovinale M, Verrecchia E,  Montalto M, De Socio G, Soriano A, La Regina M, Gasbarrini G. Clinical features of familial Mediterranean fever: an Italian overview. Eur Rev Med Pharmacol Sci. 2009;13 Suppl 1:51-53.
  28. Ebrahimi-Fakhari D, Schönland SO, Hegenbart U, Lohse P, Beimler J, Wahlster L, et al. Familial Mediterranean fever in Germany: clinical presentation and amyloidosis risk. Scand J Rheumatol. 2013;42(1):52-8.
  29. Ozen S. Mutations/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol. 2009;27(2 Suppl 53):S29-S31.
  30. Özçakar ZB, Elhan AH, Yalçınkaya F. Can colchicine response be predicted in familial Mediterranean fever patients? Rheumatology (Oxford) 2014;53(10):1767-72.
  31. Kallinich T, Haffner D, Niehues T, Huss K, Lainka E, Neudorf U, et al. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics 2007;119(2):e474-e483.
  32. Ozturk A, Elbosky E, Elsayed SM, Alhodhod M, Akar N. Mutational analysis of the MEFV gene in Egyptian patients with familial Mediterranean fever. Turk J Med Sci 2009;39:229-34. 
  33. Kincir M, Duksal F, Cevit O, Fatih B, Guven AS, Oflaz MB, et al. Association of clinical and genetic features in familial Mediterranean fever among children from central Anatolia, Turkey. Proc Natl Acad Sci India B 2015;85(3):793-800. 
  34. Bodur H, Uçan H, Seçkin S, Seçkin Ü, Gündüz O. H. Protracted familial Mediterranean fever arthritis. Rheumatol Int 1999;19(1-2):71-73.
  35. Tomiyama N, Higashiuesato Y, Oda T, Baba E, Harada M, Azuma M, et al. MEFV mutation analysis of familial Mediterranean fever in Japan. Clin Exp Rheumatol 2008;26:13-7.
  36. Balci B. MEFV gene mutations in familial Mediterranean fever phenotype II patients with renal amyloidosis in childhood: a retrospective clinicopathological and molecular study. Nephrol Dial Transpl 2002;17(11):1921-3.
  37. Stoffman N, Magal N, Shohat T, Lotan R, Koman S, Oron A, et al. Higher than expected carrier rates for familial Mediterranean fever in various Jewish ethnic groups. Eur J Hum Genet 2000;8:307-10.
  38. Ben-Chetrit E, Lerer I, Malamud E DC, Abeliovich D. The E148Q mutation in the MEFV Gene: Is It a disease-causing mutation or a sequence variant? Hum Mutat 2000;15:385-6.
  39. Aydın F, Çakar N, Özçakar ZB, Uncu N, Başaran Ö, Özdel S, et al. Clinical features and disease severity of Turkish FMF children carrying E148Q mutation. J Clin Lab Anal 2019 May;33(4):e22852.